Two Sigma Investments, LP Immunic, Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Immunic, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 254,613 shares of IMUX stock, worth $282,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares

254,613

Previous 116,494 118.56%

Holding current value

$282,620

Previous $174,000 93.1%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.14 - $1.53 $157,455 - $211,322	138,119 Added 118.56%	254,613 $336,000
Q4 2023 Feb 14, 2024	SELL	$0.97 - $1.6 $228,893 - $377,556	-235,973 Reduced 66.95%	116,494 $174,000
Q3 2023 Nov 14, 2023	BUY	$1.35 - $2.87 $246,747 - $524,567	182,776 Added 107.71%	352,467 $518,000
Q2 2023 Aug 14, 2023	SELL	$1.33 - $2.51 $160,899 - $303,652	-120,977 Reduced 41.62%	169,691 $425,000
Q1 2023 May 15, 2023	BUY	$1.35 - $2.87 $12,964 - $27,560	9,603 Added 3.42%	290,668 $433,000

Q4 2022 Feb 14, 2023	BUY	$1.13 - $1.51 $193,574 - $258,670	171,305 Added 156.07%	281,065 $393,000
Q3 2022 Nov 14, 2022	SELL	$3.21 - $5.49 $280,846 - $480,325	-87,491 Reduced 44.36%	109,760 $347,000
Q2 2022 Aug 15, 2022	BUY	$3.13 - $12.25 $382,022 - $1.5 Million	122,052 Added 162.31%	197,251 $684,000
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $517,621 - $773,719	-54,258 Reduced 41.91%	75,199 $850,000
Q4 2021 Feb 14, 2022	SELL	$7.34 - $10.25 $77,877 - $108,752	-10,610 Reduced 7.57%	129,457 $1.24 Million
Q3 2021 Nov 15, 2021	SELL	$8.05 - $13.29 $113,448 - $187,295	-14,093 Reduced 9.14%	140,067 $1.24 Million
Q2 2021 Aug 16, 2021	BUY	$11.76 - $16.85 $2,081 - $2,982	177 Added 0.11%	154,160 $1.89 Million
Q1 2021 May 17, 2021	SELL	$14.21 - $25.3 $647,379 - $1.15 Million	-45,558 Reduced 22.83%	153,983 $2.45 Million
Q4 2020 Feb 16, 2021	BUY	$14.8 - $20.37 $209,390 - $288,194	14,148 Added 7.63%	199,541 $3.05 Million
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $2.01 Million - $3.76 Million	171,074 Added 1194.73%	185,393 $3.44 Million
Q2 2020 Aug 14, 2020	BUY	$5.67 - $15.86 $81,188 - $227,099	14,319 New	14,319 $174,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

57.6M

Call Options Held

600

Put Options Held

254K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33.9M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Immunic, Inc. Transaction History